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Abstract
Background: Hypertension contributes to a significant burden of cardiovascular disease in low- and middle-income
countries; however, responses are inadequate because of a lack of conclusive evidence on population-based
approaches to hypertension control.
Methods/design: The objective of the present study is to determine the effect of family-based home health
education and blood pressure monitoring by trained female community health volunteers. The primary outcome
is change in mean systolic blood pressure. A community-based, open-masked, two-armed, cluster-randomized
trial will be conducted in Lekhnath Municipality of Nepal. The municipality is divided into 15 administrative
clusters. Randomization will be conducted for 14 clusters: 7 for the intervention arm and 7 for the control arm.
The participants were recruited from a prevalence study conducted earlier. On the basis of population proportion
size, 929 individuals for the intervention group and 709 individuals for the control group will participate in the
study. Due to the nature of the study, study participants are not compensated or insured. As part of the blood
pressure intervention, trained female community health volunteers will conduct home visits for health
education and blood pressure measurement. The primary outcomes will be modeled by using multiple linear
regression analysis.
Discussion: This project will be an investigation of a community-based intervention to control blood pressure
in countries with limited resources. The study will provide detailed information on the burden of blood
pressure and also whether treatment targets are being met. Moreover, evidence will be provided on the future
role of female community health volunteers for hypertension management in Nepal. The lessons learned from
this study may also be replicated in other rural areas of Nepal and elsewhere in the world with similar settings.
Trial registration: ClinicalTrials.gov NCT02428075. Registered on 23 April 2015.
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Background
The burden of hypertension worldwide contributes
significantly to heart failure, coronary artery events,
stroke, kidney failure, disability, and premature death
[1]. Modifiable lifestyle behaviors such as tobacco use,
physical inactivity, unhealthy diet, and alcohol abuse
are the major risk factors contributing to the rising
incidence of high blood pressure [2]. A population-
based approach to decreasing blood pressure levels in
the general population by even modest levels has the
potential to substantially reduce morbidity and mor-
tality and possibly to delay the onset of hypertension
[3]. It has been estimated that a 5-mmHg reduction
of systolic blood pressure (SBP) in the population
would result in a 14 % overall reduction in mortality
due to stroke, a 9 % reduction in mortality due to
coronary heart disease, and a 7 % decrease in all-
cause mortality [3, 4]. A study published in 1998
showed that the association between blood pressure
and stroke in East Asia seems higher than in Western
populations. A population-wide reduction of 3 mmHg in
diastolic blood pressure is predicted to eventually decrease
the number of strokes by about one-third [5].
However, community-based protocols to reduce blood
pressure via lifestyle interventions remain poorly de-
fined. Two studies on health promotion for blood pres-
sure reduction have yielded inconclusive results [6, 7].
We have identified deficiencies in study design in a
number of previous studies, such as contamination bias.
For example, there has been a lack of detail about health
workers, and many were demonstration projects without
a concomitant control group [8–13]. Reduction of diet-
ary salt in Sub-Saharan Africa lowered blood pressure in
the short term [14], and a study conducted in Pakistan
showed small but significant differences in blood pres-
sure among children and young adults in the interven-
tion group compared with the control group [15].
However, there is still a lack of evidence on effective
protocols for community health worker population ap-
proaches to reducing blood pressure in normotensive,
prehypertensive, and hypertensive groups. Indeed, we
noted in our previous meta-analysis that there is a vari-
able prevalence of hypertension across South Asian As-
sociation for Regional Cooperation countries, with
people in a number of countries having blood pressure
above the global average. In Nepal, the prevalence of
hypertension ranges from 22 % to 34 % [16]. We also
noted that studies are not consistent in their data col-
lection methods regarding hypertension and related
modifiable risk factors [16]. Hence, a benefit of the
present study will be to provide an accurate prevalence
rate and risk factors for hypertension, and also to de-
sign an intervention for hypertension management at
the community level.
One of the possibilities for addressing emerging hyper-
tension in low- and middle-income countries could be
by involving community health workers, such as female
community health volunteers (FCHVs) in the setting of
Nepal [17]. In Nepal, there are over 50,000 FCHVs work-
ing to improve the health of their communities [18], and
they are highly recognized for the contribution they have
made to improving maternal and child health [19].
Nepal’s Ministry of Health and Population relies on
FCHVs to act as health resources in their villages by
educating their neighbors about important health issues
and providing basic health services in the absence of
other biomedical resources.
FCHVs are selected by members of Mothers’ Group
for Health with the help of local health facility staff.
They receive 18 days of basic training in two phases (9
+ 9 days) on selected primary health care components.
The current role of the FCHV is to promote health and
healthy behaviors of community-dwelling people to pro-
mote safe motherhood, child health, and family planning
[18]. According to the National Female Community
Health Volunteer Survey, the median age of FCHVs is
37 years, and 42 % have completed primary school edu-
cation or higher [20]. Despite FCHVs’ positive record of
collaborating with the official health system, these cadres
have yet to be mobilized for prevention, control, and
treatment of hypertension. The initial service to be pro-
moted in the present trial design is for the FCHV to be
skilled in monitoring blood pressure, providing health
promotion counseling, and referring at-risk patients to
the nearest health center for hypertension treatment. In
our earlier feasibility study, FCHVs expressed willingness
and readiness to be trained in hypertension management
[21]. The FCHVs serve as a unique link between the
health facilities and local communities, and they have
the potential to play an important role in promoting
knowledge and awareness of healthier lifestyles and
thereby reducing the risk of hypertension. Thus, the aim
of this study protocol is to determine the effect of
family-based home health education and screening of
blood pressure in adults by FCHVs in Nepal.
Methods/design
Study design and setting
A community-based, open-masked, two-armed, cluster-
randomized trial will be conducted in Lekhnath Munici-
pality of Nepal. The municipality is located in the west-
ern region of Nepal, about 180 km west of Kathmandu.
The total population of the municipality was 58,816 in
the census carried out in 2011. The municipality is di-
vided into 15 smaller units called wards. The municipal-
ity is a semiurban area with limited health services
comprising one primary health care center, three sub-
health posts, and two urban health care centers.
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According to information provided by District Public
Health Office, Kaski in 2013, there were 123 FCHVs in
the municipality. No community-based interventions for
hypertension at the population level have been carried
out in this region to date.
Recruitment
A population framework of all eligible participants will
be prepared from the voter list prepared by the Election
Commission in 2007. As of 15 December 2006, all the
people included in the voter list were at least 18 years
old. By 2015, all the people in the voter list were at least
25 years of age. The voter list also contains information
about the household. Using the voter list, a survey will
be carried out by trained health professionals such as
nurses and health assistants to estimate the proportion
of hypertension in the municipality as well as to prepare
a list of eligible respondents to participate in our ran-
domized controlled trial. The data enumerators will re-
ceive 5 days of intensive training before collecting data.
If there is more than one participant from the same
household eligible to participate in the study at the
time of data collection, the Kish method will be
adopted to select the participant [22]. The survey tool
will be adapted from the World Health Organization
(WHO) STEPwise approach to surveillance [23], which
includes physical measurement (height, weight), socio-
demographic information (e.g., age, sex, family size,
occupation, income, education), lifestyle factors (e.g.,
salt consumption, smoking, alcohol, physical activity),
and blood pressure measurement. The classification of
normotension, prehypertension, and hypertension is
shown in Table 1.
During that survey, normotensive, prehypertensive,
and hypertensive participants will be identified and
asked to participate in the study. From among eligible
participants, the required sample size of respondents will
be chosen in proportion to the population of the specific
ward to be sampled. On the fifth day of training, FCHVs
from one cluster will sit together and allocate the num-
ber of households that has to be visited on the basis of
the baseline survey. After that, FCHVs will visit each
household, meet the selected participant, and ask for
consent to participate in the trial.
Randomization
Of 15 wards (clusters), 1 ward will be excluded by lot-
tery method before randomization. Clusters will be
randomly assigned to intervention and control areas
using a 1:1 allocation ratio. Randomization will be
done before the participants are recruited. Research
teams responsible for identifying potential partici-
pants, obtaining consent, and recruiting trial partici-
pants will be blinded to the participants’ allocation
status. The following steps will be taken to avoid se-
lection bias during random allocation: (1) clusters will
be randomized only after the baseline survey; (2) clus-
ters will not be withdrawn from or added to the study;
and (3) an epidemiologist who does not come in con-
tact with the study will randomize the clusters.
Inclusion and exclusion criteria
People 25–65 years of age who are listed in the voter list
of 2007 are eligible for inclusion in the baseline survey.
The primary endpoint of the study is a reduction in SBP,
because with aging there is an increase in SBP due to
aortic stiffening [24]. This may not be modifiable
through reduction in risk factors. Hence, we have de-
fined an adult population within an age range who will
likely respond to reductions in hypertension risk factors
through educational interventions. Participants for the
blood pressure education intervention study will be
chosen from among the respondents who participated in
the baseline survey and who live in a ward in the study
area. Persons who are severely ill, who are unlikely to be
in the community throughout the intervention, who are
pregnant women, and who decline consent will be ex-
cluded from the study.
Primary and secondary outcomes
The primary outcome of the study is a reduction in
mean SBP among normotensive, prehypertensive, and
hypertensive populations. The secondary outcomes of
the study are reductions in mean diastolic blood pres-
sure and proportion of risk factors (smoking, alcohol,
salt intake, body mass index).
Sample size calculation
The sample size for the population prevalence study is
estimated according to the method suggested in the
WHO STEPwise approach [23]. We calculated the
Table 1 Classification of normotension, prehypertension, and
hypertension













DBP diastolic blood pressure, SBP systolic blood pressure
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sample size for 95 % CI (z = 1.96) on the basis of a 5 %
margin of error (α), a 25 % estimated prevalence of
hypertension based on the latest nationwide study in
Nepal [25], a design effect of 1, and a response rate of
80 %. We will include only an age group ≥ 25 years old,
resulting in a total of four age groups for each sex (total
strata = 8). This will result in a sample size equal to
2882. The participants in the baseline survey will be eli-
gible to participate in the intervention study. For the
intervention study, we took the reference of the mean
difference and SD from studies conducted in Vietnam
and Taiwan [26, 27]. As our project is randomized and
includes visits by community health workers who meas-
ure blood pressure for screening additionally, we are
hopeful that we will observe a 5-mmHg difference in
mean SBP between the control and intervention arms.
The detailed assumptions of the sample size calculation
are presented in Table 2.
Intervention
After randomization, the FCHVs participating in the inter-
vention wards will receive a 5-day training package featur-
ing (1) introduction and importance of noncommunicable
disease and/or hypertension; (2) identifying populations at
risk using a checklist comprising level of salt intake, phys-
ical inactivity, smoking, and alcohol consumption; (3)
blood pressure screening by using digital sphygmoma-
nometers, height and weight measurement, and referral
for those whose blood pressure is > 140/90 mmHg; (4)
providing health education in major risk factors; and (5)
recording, reporting, and follow-up. Educational sessions
are guided by use of the Health Belief Model [28], and
training materials will be developed by involving local
major stakeholders. The developed materials will be pre-
tested with the FCHVs of Pokhara Municipality.
After receiving the training, the FCHVs will be given a
digital sphygmomanometer, manual weighing scale, clin-
ical measuring tape for height, an FCHV manual, and a
recording register. During the training program, FCHVs
will allocate the households themselves. On average, 1
FCHV will visit 25 households (13 normotensive, 5 pre-
hypertensive, and 7 hypertensive). Each FCHV will visit
selected households three times during 1 year, where the
FCHV will provide counseling and measure the blood
pressure as well as the height and weight of selected re-
spondents. If the participant is hypertensive, the FCHV
will ask the respondent to visit the health facility for
further diagnosis and treatment. For hypertensive par-
ticipants, the FCHV will also monitor whether the re-
spondent is taking medicine as per the advice of health
care workers. Participants in the control clusters will
receive usual care. Usual care means current practices
related to hypertension management at the community
level. After the 1-year period of the intervention, a
follow-up survey will be carried out through trained
professional health workers such as nurses and health
assistants.
Minimization of contamination
The risk and level of contamination will be monitored at
the levels of FCHVs and participants. FCHVs will be
instructed not to share information about the study and
not to provide any support to people from other clusters
in the community, other than the ones who are assigned.
The risk of contamination will also be minimized by the
cluster design, whereby the intervention and control
clusters will be geographically separated and the chance
of intervention cluster participants regularly meeting
control cluster participants will be negligible. Further,
we will collect all possible means of contamination be-
tween intervention and control participants during the
follow-up survey, and, if these are found to be signifi-
cant, we will make adjustments while estimating the
effect.
Intervention fidelity
Intervention fidelity refers to the extent to which core
components of interventions are delivered as intended
in the protocols. Ensuring and measuring fidelity are im-
portant in detecting the effects of the intervention [29].
In the present study, a number of steps will be imple-
mented to facilitate fidelity. The importance of fidelity
will be explained to FCHVs of intervention clusters dur-
ing the training session. FCHVs will also receive a regis-
ter to remind them of the stages of the intervention and
to assist the research team to monitor its delivery. Every
4 months, they will report to the research team the ac-
tivities they have carried out.
Data analysis
The quantitative analysis will be done using STATA
version 14 software (StataCorp, College Station, TX,











Normotensive 5 18.8 0.01 1.57 7 406 812
Prehypertensive 5 13.6 0.01 1.23 7 168 336
Hypertensive 5 15.7 0.01 1.34 7 245 490
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USA) following the Consolidated Standards of Report-
ing Trials (CONSORT) guidelines for cluster-
randomized trials. Flowcharts (Fig. 1) will include the
number of participants seen at each stage of the trial,
including the number screened, eligible, randomized,
and analyzed for the primary outcome. In initial ana-
lysis, we will compare baseline characteristics of en-
rolled participants in the study intervention arm and
follow-up status. The primary analyses will be
intention to treat at the 12-month follow-up, adjusted
for the baseline measure of the outcome. In the event that
randomization does not control for differences between
the treatment and control groups on baseline characteris-
tics, we will statistically control for those differences in
subsequent analyses of program effects. The final outcome
will be modeled by using random - effects regression
models. The effect size will be reported as mean differ-
ences with 95 % CIs for primary data.
Fig. 1 Planned flow of participants through the trial. FCHV female community health volunteer
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Interim analyses and stopping rules
We do not have a plan for interim analysis, as we do not
expect a situation that would lead us to stop the study.
However, in the event of an extreme situation such as a
natural disaster, a conflict, or duplication of similar in-
terventions in our control area, we will temporarily stop
the study to assess the implications on the study design.
Trial management
We have a robust mechanism to ensure data quality.
First, the data enumerator will receive intensive train-
ing on the process of data collection. The principal
investigator will monitor the data enumerator on a
day-to-day basis. The data entry clerk will inspect the
data manually at first and enter the data in an EpiData
software file (EpiData Association, Odense, Denmark).
Ten percent of the data will be double-entered to qual-
ify potential errors in data entry quality. The research
support officer will cross-check the data quality on the
spot and in our field office for any incomplete, incon-
sistent, and invalid data. Any deviation in the data
quality will require retesting in the field.
Indemnities
The study carries very minimal risk to the study partici-
pants, which is why we have no compensation or insur-
ance plan for the participants. However, we will provide
US$5 per home visit to FCHVs for transportation
expenses.
Publication plan
We are planning to publish the results of the trial as a
peer-reviewed publication in a PubMed-listed journal.
Discussion
Models of health service provided by lay health workers
are operational in several underresourced countries, in-
cluding India, Kenya, Uganda, Ghana, Ethiopia, South
Africa, and China [30]. Previous studies have shown that
community health worker programs for health care de-
livery are significantly beneficial in maternal and child
health as well as infectious disease control [30, 31].
However, involving community health workers for non-
communicable diseases has not gained much attention
until recently. This study pioneers the investigation of a
community-based intervention to reduce blood pressure
in resource-poor countries. If our study shows that the
intervention is effective, a scaled-up approach could pro-
duce an important reduction in cardiovascular disease
burden due to hypertension. The proposed study will in-
crease knowledge on how to control blood pressure by
mobilizing community health volunteers in Nepal. Thus,
the research output of this study has the potential to
bring immediate benefits to address noncommunicable
diseases in Nepal. Assessing the FCHVs’ capacity for
identifying hypertensive patients and for reducing risk
factors related to hypertension may contribute to devel-
oping a policy that can be scaled up to a national level.
The lessons learned from this study may also be repli-
cated in other rural areas of Nepal and elsewhere in the
world with similar settings.
Trial status
Trial has been closed to participant accrual, but trial is
ongoing. The endpoint assessment of all the participants
will be completed by the end of November 2016. The
final outcome assessment of all the participants will be
completed by the end of December 2016. The schedule
of enrollment, interventions, and assessments is pre-
sented in Additional file 1.
Additional file
Additional file 1: Schedule of enrollment, interventions, and assessments.
(DOC 46 kb)
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